Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MULTIHANCE safely and effectively. See full prescribing information for MULTIHANCE.MultiHance (gadobenate dimeglumine) InjectionInitial U.S. Approval: 2004
Medication labelWhy this: Advisory · dailymed-prescription
MultiHance is indicated for intravenous use in magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults and pediatric patients (including term neonates), to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues. MultiHance is indicated for use in magnetic resonance angiography (MRA) to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive vascular disease.
- generic_name
- gadobenate dimeglumine
- product_names
- gadobenate dimeglumine
- ndc
- 0270-5164, 0270-5164-12, 0270-5164-13, 0270-5164-14, 0270-5164-15
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en